We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GIS:NYSEGeneral Mills, Inc. Analysis

Data as of 2026-05-24 - not real-time

$33.69

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

General Mills trades well below its intrinsic valuation, with a price‑to‑earnings multiple comfortably under ten and a dividend yield that tops seven percent, offering a compelling income cushion. The stock sits beneath its short‑term moving averages, indicating a bearish technical backdrop, yet it remains above a solid support zone and benefits from stable trading volume. Recent leadership changes, including the promotion of a new chief operating officer, signal a focus on product innovation such as bold‑flavored fruit snacks that align with current snacking trends. Valuation models point to a substantial upside potential, while the company’s strong free cash flow and modest payout ratio support dividend sustainability. The consumer defensive sector provides a defensive moat, though modest revenue growth and a modest operating margin suggest limited high‑growth upside. Overall, the blend of attractive yield, undervalued pricing, and strategic product rollout creates a balanced risk‑reward profile.
Investors should weigh the short‑term bearish technical signals against the long‑term fundamentals, with particular attention to the dividend’s reliability and the upside indicated by discounted cash‑flow analysis.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish technical positioning below short‑term averages
  • Robust dividend yield providing immediate income
  • Support level near recent lows limiting downside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation upside relative to discounted cash‑flow estimate
  • Stable cash flow and manageable payout ratio
  • Product innovation aimed at current snacking trends

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Defensive consumer staples positioning
  • Sustainable dividend supported by strong free cash flow
  • Long‑term upside from strategic brand and product expansion

Key Metrics & Analysis

Financial Health

Revenue Growth2.20%
Profit Margin12.05%
P/E Ratio8.2
ROE23.59%
ROA5.31%
Debt/Equity217.63
P/B Ratio3.3
Op. Cash Flow$2.2B
Free Cash Flow$2.3B

Technical Analysis

TrendBearish
RSI40.9
Support$32.64
Resistance$35.94
MA 20$34.20
MA 50$35.58
MA 200$44.37
MACDBullish
VolumeStable
Fear & Greed Index91.61

Valuation

Fair Value$61.45
Target Price$39.79
Upside/Downside18.10%
GradeUndervalued
TypeValue
Dividend Yield7.24%

Risk Assessment

Beta-0.12
Volatility22.49%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.